Prions and the oral cavity

Journal of Dental Research

Volumn 82, Issue 10, 2003, Pages 769-775

  Smith, A J ^a   Bagg, J ^a   Ironside, J W ^b   Will, R G ^b   Scully, C ^c  

^a GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dentistry; Infection control; Oral cavity; Prions

Indexed keywords

ANIMAL; CATTLE; CHEMISTRY; DISEASE MODEL; DISEASE TRANSMISSION; HUMAN; ISOLATION AND PURIFICATION; MOUTH; PATHOGENICITY; PRION; PRION DISEASE; REVIEW; TOOTH;

ANIMALS; CATTLE; DISEASE MODELS, ANIMAL; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; HUMANS; MOUTH; PRION DISEASES; PRIONS; TOOTH;

EID: 0242335940     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910308201002     Document Type: Short Survey

References (41)

1. ACDP/SEAC (1998). Advisory Committee on Dangerous Pathogens and Spongiform Encephalopathy Advisory Committee Transmissible Spongiform Encephalopathy Agents: safe working and the prevention of infection. London: Her Majesty's Stationery Office.
2. Adams DH, Edgar WM (1978). Transmission of agent of Creutzfeldt-Jakob disease (research letter). Br Med J 1:987.
3. Andrews NJ, Farrington CP, Ward HJ, Cousens SN, Smith PG, Molesworth AM, et al. (2003). Deaths from variant Creutzfeldt-Jakob disease in the UK. Lancet 361:751-752.
4. Arakawa K, Nagara H, Itoyama Y, Doh-ura K, Tomokane N, Tateishi J, et al. (1991). Clustering of three cases of Creutzfeldt-Jakob disease near Fukuoka City, Japan. Acta Neurol Scand 84:445-447.
5. Bartz JC, Kincaid AE, Bessen RA (2003). Rapid prion neuroinvasion following tongue infection. J Virol 77:583-591.
6. Bernoulli C, Siegfried J, Baumgartner G, Regli F, Rabinowicz T, Gajdusek DC, et al. (1977). Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1:478-479.
7. Blanquet-Grossard F, Sazdovitch V, Jean A, Deslys JP, Dormont D, Hauw JJ, et al. (2000). Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob disease. J Dent Res 79:700.
8. Bolton DC, McKinley MP, Prusiner SB (1982). Identification of a protein that purifies with the scrapie prion. Science 218:1309-1311.
9. Borchelt DR, Koliatsos VE, Guarnieri M, Pardo CA, Sisodia SS, Price DL (1994). Rapid anterograde axonal transport of the cellular prion glycoprotein in the peripheral and central nervous systems. J Biol Chem 269:14711-14714.
10. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, et al. (1994). Human spongiform encephalopathy: the National Institute of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 35:513-529.
11. Brown P, Preece M, Brandel JP, Sato L, McShane L, Zerr I, et al. (2000). Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55:1075-1081.
12. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, et al. (1997). Transmissions to mice indicate that "new variant" CJD is caused by the BSE agent. Nature 389:498-501.
13. Bruce ME, McConnell I, Will RG, Ironside JW (2001). Detection of variant Creutzfeldt-Jakob disease infectivity in extraneural tissues. Lancet 358:208-209.
14. Bueler HR, Aguzzi A, Sailer A, Greiner RA, Autenried P, Aguet M, et al. (1993). Mice devoid of PrP are resistant to scrapie. Cell 73:1339-1347.
15. Carp RI (1982). Transmission of scrapie agent by oral route: effect of gingival scarification. Lancet 1:170-171.
16. Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL (1999). Surgical treatment and risk of sporadic Creutzfeldt-Jacob disease: a case-control study. Lancet 353:693-697.
17. Davanipour Z, Alter M, Sobel E, Asher D, Gajdusek DC (1985). Creutzfeldt-Jakob disease: possible medical risk factors. Neurology 35:1483-1486.
18. Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D (1974). Possible person-to-person transmission of Creutzfeldt-Jakob disease (letter). N Engl J Med 290:692-693.
19. Eklund CM, Kennedy RC, Hadlow WJ (1967). Pathogenesis of scrapie virus infection in the mouse. J Infect Dis 117:15-22.
20. Groschup MH, Beekes M, McBride PA, Hardt M, Hainfellner JA, Budka H (1999). Deposition of disease associated prion protein involves the peripheral nervous system in experimental scrapie. Acta Neuropathol 98:453-457.
21. Guiroy DC, Shankar SK, Gibbs CJ Jr, Messenheimer JA, Das S, Gajdusek DC (1989). Neuronal degeneration and neurofilament accumulation in the trigeminal ganglia in Creutzfeldt-Jakob disease. Ann Neurol 25:102-106.
22. Hadlow WJ, Kennedy RC, Race RE (1982). Natural infection of Suffolk sheep with scrapie virus. J Infect Dis 146:657-664.
23. Hadlow WJ, Race RE, Kennedy RC (1987). Temporal distribution of transmissible mink encephalopathy virus in mink inoculated subcutaneously. J Virol 61:3235-3240.
24. Hilton DA, Fathers E, Edwards P, Ironside JW, Zajicek J (1998). Prion immunoreactivity in appendix before the clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352:703-704.
25. Ingrosso L, Pisani F, Pocchiari M (1999). Transmission of the 263K scrapie strain by the dental route. J Gen Virol 80:3043-3047.
26. Ironside JW, Head MW, Bell JE, McCardle L, Will RG (2000). Laboratory diagnosis of variant Creutzfeldt-Jakob disease. Histopathology 37:1-9.
27. Ironside JW, McCardle L, Horsburgh A, Lim Z, Head MW (2002). Pathological diagnosis of variant Creutzfeldt-Jakob disease. APMIS 110:79-87.
28. Kondo K, Kuroiwa Y (1982). A case control study of Creutzfeldt-Jakob disease: association with physical injuries. Ann Neurol 11:377-381.
29. Maignien T, Lasmezas CI, Beringue V, Dormont D, Deslys JP (1999). Pathogenesis of the oral route of infection of mice with scrapie and bovine spongiform encephalopathy agents. J Gen Virol 80:3035-3042.
30. Marx RE, Carlson ER (1991). Creutzfeldt-Jakob disease from allogeneic dura: a review of risks and safety. J Oral Maxillofac Surg 49:272-274.
31. Muramoto T, Kitamoto T, Tateishi J, Goto I (1993). Accumulation of abnormal prion protein in mice infected with Creutzfeldt-Jakob disease via intraperitoneal route: a sequential study. Am J Pathol 143:1470-1479.
32. Pattison IH, Millson GC (1962). Distribution of the scrapie agent in the tissues of experimentally inoculated goats. J Comp Pathol Therap 72:233-244.
33. Prusiner SB (2001). Shattuck lecture - neurodegenerative diseases and prions. N Engl J Med 20:1516-1526.
34. Sakaguchi S, Katamine S, Yamanouchi K, Kishikawa M, Moriuchi R, Yasukawa N, et al. (1993). Kinetics of infectivity are dissociated from PrP accumulation in salivary glands of Creutzfeldt-Jakob disease agent-inoculated mice. J Gen Virol 74:2117-2123.
35. Smith AJ, Dickson M, Aitken J, Bagg J (2002). Contaminated dental instruments. J Hosp Infect 51:233-235.
36. Taylor DM (1999). Inactivation of prions by physical and chemical means. J Hosp Infect 43(Suppl):S69-S76.
37. van Duijn CM, Delasnerie-Laupretre N, Masullo C, Zerr I, de Silva R, Wientjens DP, et al. (1998). Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet 351:1081-1085.
38. Wells GA, Hawkins SA, Green RB, Austin AR, Dexter I, Spencer YI, et al. (1998). Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec 142:103-106.
39. WHO/CDS/APH/2000.3. WHO infection control guidelines for transmissible spongiformencephalopathies (www.who.int/csr/resources/publications/bse/ WHO_CDS_CSR_A PH_2000_3/en/).
40. Will RG, Matthews WB (1982). Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 45:235-238.
41. Zobeley E, Flechsig E, Cozzio A, Enari M, Weissmann C (1999). Infectivity of scrapie prions bound to a stainless steel surface. Mol Med 5:240-243.